Fenchylamine Sulfonamide Inhibitors of Amyloid β Peptide Production by the γ-Secretase Proteolytic Pathway: Potential Small-Molecule Therapeutic Agents for the Treatment of Alzheimer's Disease
- 23 May 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (12) , 2297-2299
- https://doi.org/10.1021/jm990622z
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- The role of Aβ42 in Alzheimer's diseaseJournal of Physiology-Paris, 1998
- Polymer-Supported Quenching Reagents for Parallel PurificationJournal of the American Chemical Society, 1997
- Alzheimer's Disease--Genotypes, Phenotype, and TreatmentsScience, 1997
- Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activitiesProceedings of the National Academy of Sciences, 1996
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.Journal of Biological Chemistry, 1993
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984